{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:39:19Z","timestamp":1773211159005,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,10]],"date-time":"2016-09-10T00:00:00Z","timestamp":1473465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10753-016-0443-y","type":"journal-article","created":{"date-parts":[[2016,9,10]],"date-time":"2016-09-10T04:21:38Z","timestamp":1473481298000},"page":"2053-2061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Novel Piperazino-Enaminones Suppress Pro-Inflammatory Cytokines and Inhibit Chemokine Receptor CCR2"],"prefix":"10.1007","volume":"39","author":[{"given":"Doreen E.","family":"Szollosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola A. M.","family":"Ghoneim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed K.","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyothi","family":"Dhuguru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan O.","family":"Edafiogho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,10]]},"reference":[{"key":"443_CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.0711357","volume":"91","author":"M Yang","year":"2012","unstructured":"Yang, M., R.K. Kumar, P.M. Hansbro, and P.S. Foster. 2012. Emerging roles of pulmonary macrophages in driving the development of severe asthma. Journal of Leukocyte Biology 91: 557\u2013569.","journal-title":"Journal of Leukocyte Biology"},{"key":"443_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2009.08.010","volume":"49","author":"X Li","year":"2010","unstructured":"Li, X., S. Jiang, and R.I. Tapping. 2010. Toll-like receptor signaling in cell proliferation and survival. Cytokine 49: 1\u20139.","journal-title":"Cytokine"},{"key":"443_CR3","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.4049\/jimmunol.167.10.5887","volume":"167","author":"T Kawar","year":"2001","unstructured":"Kawar, T., O. Takeuchi, T. Fujita, J. Inoue, P. Muhlradt, S. Sato, K. Hoshino, and S. Akira. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. Journal of Immunology 167: 5887\u20135894.","journal-title":"Journal of Immunology"},{"key":"443_CR4","volume-title":"Pharmacotherapy: A Pathophysiologic Approach","author":"J DiPiro","year":"2001","unstructured":"DiPiro, J., R.L. Talbert, G.C. Yee, G.R. Matzke, B.G. Wells, and L.M. Posey. 2001. Pharmacotherapy: A Pathophysiologic Approach, 8th ed. New York: McGraw-Hill Education.","edition":"8"},{"key":"443_CR5","first-page":"107","volume":"6","author":"N Singh","year":"2004","unstructured":"Singh, N., M.J. Rieder, and M.J. Tucker. 2004. Mechanisms of glucocorticoid-mediated anti-inflammatory and immunosuppressive action. Pediatric and Perinatal Drug Therapy 6: 107\u2013115.","journal-title":"Pediatric and Perinatal Drug Therapy"},{"key":"443_CR6","doi-asserted-by":"crossref","first-page":"29603","DOI":"10.1074\/jbc.M101522200","volume":"276","author":"PR Mittelstadt","year":"2001","unstructured":"Mittelstadt, P.R., and J.F. Ashwell. 2001. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. Journal of Biological Chemistry. 276: 29603\u201329610.","journal-title":"Journal of Biological Chemistry."},{"key":"443_CR7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2002-02-0538","volume":"101","author":"D Berrebi","year":"2003","unstructured":"Berrebi, D., S. Bruscoli, N. Cohen, A. Foussat, G. Migliorati, L. Bouchet-Delbos, M.C. Maillot, A. Portier, J. Couderc, P. Galanaud, M. Peuchmaur, C. Riccardi, and D. Emilie. 2003. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunesuppresive mechanism shared by glucocorticoids and IL-10. Blood 101: 729\u2013738.","journal-title":"Blood"},{"key":"443_CR8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0026-895X(25)13597-9","volume":"43","author":"Y Amano","year":"1993","unstructured":"Amano, Y., S.W. Lee, and A.C. Allison. 1993. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin 6: mediation by decreased mRNA stability. Molecular Pharmacology 43: 176\u2013182.","journal-title":"Molecular Pharmacology"},{"key":"443_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood.V79.1.45.45","volume":"79","author":"A Tobler","year":"1992","unstructured":"Tobler, A., R. Meier, M. Seitz, B. Dewald, M. Baggiolini, and M. Fey. 1992. Glucocorticoids downregulate gene expression of GM-CSF NAP1\/IL-8, and IL-6, but no M-CSF in human fibroblasts. Blood 79: 45\u201351.","journal-title":"Blood"},{"key":"443_CR10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1677\/joe.0.1780339","volume":"178","author":"RJ Farrell","year":"2003","unstructured":"Farrell, R.J., and D. Kelleher. 2003. Glucocorticoid resistance in inflammatory bowel disease. Journal of Endocrinology 178: 339\u2013346.","journal-title":"Journal of Endocrinology"},{"key":"443_CR11","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","volume":"373","author":"PJ Barnes","year":"2009","unstructured":"Barnes, P.J., and I.M. Adock. 2009. Glucocorticoid resistance in inflammatory diseases. The Lancet 373: 1905\u20131917.","journal-title":"The Lancet"},{"key":"443_CR12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2009.12.004","volume":"632","author":"A El-Hashim","year":"2010","unstructured":"El-Hashim, A., S. Yousefi, I. Edafiogho, R. Raghupathy, M. Yousif, and H.U. Simon. 2010. Anti-inflammatory and immunosuppressive effects of the enaminone E121. European Journal of Pharmacology 632: 73\u201378.","journal-title":"European Journal of Pharmacology"},{"key":"443_CR13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.lfs.2011.07.007","volume":"89","author":"A El-Hashim","year":"2011","unstructured":"El-Hashim, A., I. Edafiogho, S. Jaffal, M. Yousif, C.I. Ezeamuzie, and S. Kombian. 2011. Anti-tussive and bronchodilator mechanisms of action for the enaminone E121. Life Sciences 89: 378\u2013387.","journal-title":"Life Sciences"},{"issue":"3","key":"443_CR14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/13543770902755129","volume":"19","author":"M Xia","year":"2009","unstructured":"Xia, M., and Z. Sui. 2009. Recent developments in CCR2 antagonists. Expert Opinion on Therapeutic Patents 19(3): 295\u2013303.","journal-title":"Expert Opinion on Therapeutic Patents"},{"issue":"12","key":"443_CR15","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1016\/j.bmcl.2012.04.118","volume":"22","author":"JG Cumming","year":"2012","unstructured":"Cumming, J.G., J.F. Bower, D. Waterson, A. Faull, P. Poyser, P. Turner, B. McDermott, A.D. Campbell, J. Hudson, M. James, J. Winter, and C. Wood. 2012. The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity. Bioorganic Medicinal Chemistry Letters 22(12): 3895\u20133899.","journal-title":"Bioorganic Medicinal Chemistry Letters"},{"issue":"1","key":"443_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.171.1.11","volume":"171","author":"NW Lukacs","year":"2003","unstructured":"Lukacs, N.W., A.L. Miller, and C.M. Hogaboam. 2003. Chemokine receptors in ssthma: searching for the correct immune targets. Journal of Immunology 171(1): 11\u201315.","journal-title":"Journal of Immunology"},{"key":"443_CR17","doi-asserted-by":"crossref","unstructured":"Xu, W., A. Roos, N. Schlagwein, A.M. Woltman, M.R. Daha, and C. van Kooten. 2006. IL-10 producing macrophages preferentially clear early apoptotic cells. Blood 107(12).","DOI":"10.1182\/blood-2005-10-4144"},{"key":"443_CR18","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.4049\/jimmunol.178.11.6705","volume":"178","author":"EY Chang","year":"2007","unstructured":"Chang, E.Y., B. Guo, S.E. Doyle, and G. Cheng. 2007. Cutting edge: involvement of the type I IFN. Journal of Immunology 178: 6705\u20136709.","journal-title":"Journal of Immunology"},{"key":"443_CR19","doi-asserted-by":"crossref","unstructured":"Saraiva M, and O\u2019Garra A. 2010. The regulation of IL-10 production by immune cells. Nature Reviews Immunology\u00a010(3):170\u2013181.","DOI":"10.1038\/nri2711"},{"issue":"11","key":"443_CR20","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.4049\/jimmunol.1002041","volume":"185","author":"SS Iyer","year":"2010","unstructured":"Iyer, S.S., A.A. Ghaffari, and G. Cheng. 2010. Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. Journal of Immunology 185(11): 6599\u20136607.","journal-title":"Journal of Immunology"},{"issue":"3","key":"443_CR21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/mol.64.3.773","volume":"64","author":"MC Jimenez-Sainz","year":"2003","unstructured":"Jimenez-Sainz, M.C., B. Fast, F. Mayor Jr., and A.M. Aragay. 2003. Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation. Molecular Pharmacology 64(3): 773\u2013782.","journal-title":"Molecular Pharmacology"},{"key":"443_CR22","doi-asserted-by":"crossref","first-page":"16555","DOI":"10.1074\/jbc.M009068200","volume":"276","author":"N Ashida","year":"2001","unstructured":"Ashida, N., H. Arai, M. Yamasaki, and T. Kita. 2001. Distinct signalling pathways for MCP-1-dependent integrin activation and chemotaxis. Journal of Biological Chemistry 276: 16555\u201316560.","journal-title":"Journal of Biological Chemistry"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-016-0443-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-016-0443-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-016-0443-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:01:53Z","timestamp":1749578513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-016-0443-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,10]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["443"],"URL":"https:\/\/doi.org\/10.1007\/s10753-016-0443-y","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,10]]}}}